Tourette syndrome and tic disorders: A decade of progress

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 8, 2007, Pages 947-968

  Swain, James E ^a   Scahill, Lawrence ^a,b   Lombroso, Paul J ^a   King, Robert A ^a   Leckman, James F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Review; Tic disorder; Tourette disorder; Tourette syndrome

Indexed keywords

ARIPIPRAZOLE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; CELECOXIB; CLONAZEPAM; CLONIDINE; CYPROTERONE; DONEPEZIL; ETIRACETAM; FLUPHENAZINE; FLUTAMIDE; GUANFACINE; HALOPERIDOL; LEVODOPA; METHYLPHENIDATE; METOCLOPRAMIDE; OLANZAPINE; ONDANSETRON; PERGOLIDE; PIMOZIDE; RISPERIDONE; ROPINIROLE; SELEGILINE; SULPIRIDE; TETRABENAZINE; TIAPRIDE; TOPIRAMATE; UNINDEXED DRUG; ZIPRASIDONE;

AKATHISIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BLURRED VISION; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; DIAGNOSTIC PROCEDURE; DIET; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG DOSE INCREASE; DYSPHAGIA; DYSTONIA; EPIGENETICS; ERECTILE DYSFUNCTION; GALACTORRHEA; GENETICS; GILLES DE LA TOURETTE SYNDROME; GYNECOMASTIA; HABIT; HEALTH EDUCATION; HEREDITY; HUMAN; HYPOTENSION; IMMUNE RESPONSE; INFECTION; INJECTION SITE PAIN; LIFESTYLE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MENTAL STRESS; METABOLIC DISORDER; MOOD DISORDER; MOTOR CONTROL; MUSCLE WEAKNESS; NAUSEA; NEUROBIOLOGY; NEUROIMAGING; NEUROPHYSIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; OCULOGYRIC CRISIS; PARKINSONISM; PATHOGENESIS; PERINATAL PERIOD; PERSONALITY DISORDER; PHENOMENOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PTOSIS; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOCIAL PHOBIA; SYNCOPE; TACHYCARDIA; TARDIVE DYSKINESIA; TIME SERIES ANALYSIS; TORTICOLLIS; TRIGEMINUS NEURALGIA; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMPULSE CONTROL DISORDERS; TIC DISORDERS; TOURETTE SYNDROME;

EID: 34547653762     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e318068fbcc     Document Type: Review

References (247)

1. Abelson JF, Kwan KY, O'Roak BJ et al. (2005), Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320
2. Abuzzahab FS, Brown VL (2001), Control of Tourette's syndrome with topiramate. Am J Psychol 158:968
3. Ackermans L, Temel Y, Cath D et al. (2006), Deep brain stimulation in Tourette's syndrome: two targets? Mov Disord 21:709-713
4. Albin RL, Koeppe RA, Bohnen NI et al. (2003), Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61:310-315
5. Albin RL, Mink JW (2006), Recent advances in Tourette syndrome research. Trends Neurosci 29:175-182
6. Alexander GM, Peterson BS (2004), Testing the prenatal hormone hypothesis of tic-related disorders: gender identity and gender role behavior. Dev Psychopathol 16:407-420
7. Allen AJ, Kurlan RM, Gilbert DL et al. (2005), Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 65:1941-1949
8. Amat JA, Bronen RA, Saluja S et al. (2006), Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyperactivity disorder. Am J Psychiatry 163:1106-1108
9. American Psychiatric Association (2000), Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association
10. Anca MH, Giladi N, Korczyn AD (2004), Ropinirole in Gilles de la Tourette syndrome. Neurology 62:1626-1627
11. Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AF (2000), The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex and improves accuracy in monkeys performing a spatial working memory task. Neuropsychopharmacology 23:240-249
12. Awaad Y (1999), Tourette syndrome: new treatment options. J Child Neurol 14:316-319
13. Awaad Y, Michon AM, Minarik S (2005), Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 20:714-718
14. Banaschewski T, Woerner W, Rothenberger A (2003), Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol 45:700-703
15. Barbanti P, Fabbrini G (2004), Migraine and Tourette syndrome. Arch Neurol 61:606-607
16. Baron-Cohen S, Scahill VL, Izaguirre J, Hornsey H, Robertson MM(1999), The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study. Psychol Med 29:1151-1159
17. Biswal B, Ulmer JL, Krippendorf RL et al. (1998), Abnormal cerebral activation associated with a motor task in Tourette syndrome. AJNR Am J Neuroradiol 19:1509-1512
18. Black JK, Mink JW (2000), Response to levodopa challenge in Tourette syndrome. Mov Disord 15:1194-1198
19. Blair J, Scahill L, State M, Martin A (2005), Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study. J Am Acad Child Adolesc Psychiatry 44:73-79
20. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF (2006c), A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622-632
21. Bloch MH, Leckman JF, Zhu H, Peterson BS (2005), Caudate volumes in childhood predict symptom severity in adults of Tourette syndrome. Neurology 65:1253-1258
22. Bloch MH, Peterson BS, Scahill L et al. (2006a), Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 160:65-69
23. Bloch MH, Sukhodolsky DG, Leckman JF, Schultz RT (2006b), Finemotor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome. J Child Psychol Psychiatry 47:551-559
24. Bohlhalter S, Goldfine A, Matteson S et al. (2006), Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 129:2029-2037
25. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM (2003), Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60:1308-1312
26. Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA (2001), Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 62:50-56
27. Bruun RD, Budman CL (1996), Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 57:29-31
28. Bubl E, Perlov E, Tebartz Van Elst L (2006), Aripiprazole in patients with Tourette syndrome. World J Biol Psychiatry 7:123-125
29. Budman CL, Bruun RD, Park KS, Lesser M, Olson M (2000), Explosive outbursts in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 39:1270-1276
30. Budman CL, Gayer A, Lesser M, Shi Q, Bruun RD (2001), An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 62:290-294
31. Burd L, Severud R, Klug MG (1999), Prenatal and perinatal risk factors for Tourette disorder. J Perinat Med 27:295-302
32. Burd L, Freeman RD, Klug MG, Kerbeshian J (2005), Tourette syndrome and learning disabilities. BMC Pediatr 5:1-6
33. Chappell P, Leckman J, Goodman W et al. (1996), Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry 39:776-783
34. Canales JJ, Graybiel AM (2000), A measure of striatal function predicts motor stereotypy. Nat Neurosci 3:377-383
35. Cardona F, Orefici G (2001), Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 135:71-75
36. Carter AS, O'Donnell DA, Schultz RT, Scahill L, Leckman JF, Pauls DL (2000), Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention deficit hyperactivity disorder. J Child Psychol Psychiatry 41:215-223
37. Castellanos FX, Giedd JN, Elia J et al. (1997), Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36:589-596
38. Chae JH, Nahas Z, Wassermann E et al. (2004), A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol 17:109-117
39. Channon S, Crawford S, Vakili K, Robertson MM (2003), Real-life-type problem solving in Tourette syndrome. Cogn Behav Neurol 16:3-15
40. Chappell P, Leckman J, Goodman W et al. (1996), Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive-compulsive disorder and normal controls. Biol Psychiatry 39:776-783
41. Cheon KA, Ryu YH, Namkoong K, Kim CH, Kim JJ, Lee JD (2004), Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Res 130:85-95
42. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM (2003), Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74:602-607
43. Coffey BJ, Biederman J, Geller D et al. (2004), Reexamining tic persistence and tic-associated impairment in Tourette's disorder: findings from a naturalistic follow-up study. J Nerv Ment Dis 192:776-780
44. Coffey BJ, Biederman J, Smoller JW et al. (2000), Anxiety disorders and tic severity in juveniles with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 39:562-568
45. Cohen DJ, Leckman JF (1999), The self under siege. In: Tourette's Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care, Leckman JF, Cohen DJ, eds. New York: Wiley, pp 1-20
46. Cohen JD, Braver TS, Brown JW (2002), Computational perspectives on dopamine function in prefrontal cortex. Curr Opin Neurobiol 12:223-229
47. Cohrs S, Rasch T, Altmeyer S et al. (2001), Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome. J Neurol Neurosurg Psychiatry 70:192-197
48. Comings DE (2001), Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann N Y Acad Sci 931:50-83
49. Crawford S, Channon S, Robertson MM (2005), Tourette's syndrome: performance on tests of inhibition, working memory and gambling. J Child Psychol Psychiatry 46:1327-1336
50. Cuker A, State MW, King RA, Davis N, Ward DC (2004), Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/ chronic tic disorder at 18q22. Am J Med Genet 130:37-39
51. Curtis D, Brett P, Dearlove AM et al. (2004), Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13. Psychiatr Genet 14:83-87
52. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G (2005), Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 172:187-197
53. Davis RE, Osorio I (1998), Childhood caffeine tic syndrome. Pediatrics 101:E4
54. Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB (2003), Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling. Neuroscience 117:417-425
55. Deckersbach T, Rauch S, Buhlmann U, Wilhelm S (2006), Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther 44:1079-1090
56. Dewing P, Chiang CW, Sinchak K et al. (2006), Direct regulation of adult brain function by the male-specific factor SRY. Curr Biol 16:415-420
57. Diaz-Anzaldua A, Joober R, Riviere JB et al. Montreal Tourette Syndrome Study Group (2004), Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol Psychiatry 9:272-277
58. Dion Y, Annable L, Sandor P, Chouinard G (2002), Risperidone in the treatment of Tourette syndrome: a double-blind, placebo controlled trial. J Clin Psychopharmacol 22:31-39
59. Eapen V, Fox-Hiley P, Banerjee S, Robertson M (2004), Clinical features and associated psychopathology in a Tourette syndrome cohort. Acta Neurol Scand 109:255-260
60. Feigin A, Kurlan R, McDermott MP et al. (1996), A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 46:965-968
61. Findley DB, Leckman JF, Katsovich L et al. (2003), Development of the Yale children's global stress index (YCGSI) and its application in children and adolescents with Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 42:450-457
62. Frank MJ, Loughry B, O'Reilly RC (2001), Interactions between frontal cortex and basal ganglia in working memory: a computational model. Cogn Affect Behav Neurosci 1:137-160
63. Gadow KD, Nolan EE, Sprafkin J, Schwartz J (2002), Tics and psychiatric comorbidity in children and adolescents. Dev Med Child Neurol 44:330-338
64. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S (1999), Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 56:330-336
65. Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S (2002), Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 41:330-336
66. Garvey MA, Perlmutter J, Allen AJ et al. (1999), A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45:1564-1571
67. George MS, Sallee FR, Nahas Z, Oliver NC, Wassermann EM (2001), Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. Adv Neurol 85:225-235
68. Gerard E, Peterson BS (2003), Developmental processes and brain imaging studies in Tourette syndrome. J Psychosom Res 55:13-22
69. Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR (2003), Tic reduction with pergolide in a randomized controlled trial in children. Neurology 60:606-611
70. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR (2000), Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 54:1310-1315
71. Gonzalez-Burgos G, Krimer LS, Povysheva NV, Barrionuevo G, Lewis DA (2005), Functional properties of fast-spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. J Neurophysiol 93:942-953
72. Graybiel AM, Canales JJ (2001), The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. Adv Neurol 85:123-131
73. Hallett JJ, Harling-Berg CJ, Knopf PM, Stopa EG, Kiessling LS (2000), Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 111:195-202
74. Haber SN (2003), The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26:317-330
75. Haber SN, Fudge JL, McFarland NR (2000), Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20:2369-2382
76. Hershey T, Black KJ, Hartlein JM et al. (2004), Cognitive-pharmacologic functional magnetic resonance imaging in Tourette syndrome: a pilot study. Biol Psychiatry 55:916-925
77. Hoekstra PJ, Anderson GM, Limburg PC, Korf J, Kallenberg CG, Minderaa RB (2004a), Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci 61:886-898
78. Hoekstra PJ, Minderaa RB, Kallenberg CG (2004b), Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study. J Clin Psychiatry 65:537-542
79. Hoekstra PJ, Steenhuis MP, Troost PW, Korf J, Kallenberg CG, Minderaa RB (2004c), Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioral problems in tic disorders. J Dev Behav Pediatr 25:272-279
80. Hoffman KL, Hornig M, Yaddanapudi K, Jabado O, Lipkin WI (2004), A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J Neurosci 24:1780-1791
81. Hollenbeck PJ (2001), Insight and hindsight into Tourette syndrome. Adv Neurol 85:363-367
82. Holt DJ, Graybiel AM, Saper CB (1997), Neurochemical architecture of the human striatum. J Comp Neurol 384:1-25
83. Hong JJ, Loiselle CR, Yoon DY, Lee O, Becker KG, Singer HS (2004), Microarray analysis in Tourette syndrome postmortem putamen. J Neurol Sci 225:57-64
84. Hoopes SP (1999), Donepezil for Tourette's disorder and ADHD. J Clin Psychopharmacol 19:381-382
85. Ivanenko A, Crabtree VM, Gozal D (2004), Sleep in children with psychiatric disorders. Pediatr Clin North Am 51:51-68
86. Izmir M, Dursun SM (1999), Cyproterone acetate treatment of Tourette's syndrome. Can J Psychiatry 44:710-711
87. Jankovic J (2001), Tourette's syndrome. N Engl J Med 345:1184-1192
88. Jeffries KJ, Schooler C, Schoenbach C, Herscovitch P, Chase TN, Braun AR (2002), The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology 27:92-104
89. Jin R, Zheng RY, Huang WW et al. (2005), Epidemiological survey of Tourette syndrome in children and adolescents in Wenzhou of P.R. China. Eur J Epidemiol 20:925-927
90. Jog MS, Kubota Y, Connolly CI, Hillegaart V, Graybiel AM (1999), Building neural representations of habits. Science 286:1745-1749
91. Kadesjo B, Gillberg C (2000), Tourette's disorder: epidemiology and comorbidity in primary school children. J Am Acad Child Adolesc Psychiatry 39:548-555
92. Kalanithi PS, Zheng W, DiFiglia M et al. (2005), Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 102:13307-13312
93. Kastrup A, Schlotter W, Plewnia C, Bartels M (2005), Treatment of tics in Tourette syndrome with aripiprazole. J Clin Psychopharmacol 25:94-96
94. Kazdin AE (2003), Problem-solving skills training and parent management training for conduct disorder. In: Evidence-based Psychotherapies for Children and Adolescents, Kazdin AE, Weisz JR, eds. New York: Guilford, pp 241-262
95. Kawikova I, Leckman JF, Kronig H et al. (2007), Decreased number of regulatory T cells suggests impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61:273-278
96. Kessler AR (2002), Tourette syndrome associated with body temperature dysregulation: possible involvement of an idiopathic hypothalamic disorder. J Child Neurol 17:738-744
97. Kessler AR (2004), Effects of medications on regulation of body temperature of patients with Tourette syndrome. J Child Neurol 19:220-224
98. Kéri S, Szlobodnyik C, Benedek G, Janka Z, Gadoros J (2002), Probabilistic classification learning in Tourette syndrome. Neuropsychologia 40:1356-1362
99. Khalifa N, von Knorring AL (2003), Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 45:31531-31539
100. Khalifa N, von Knorring AL (2005), Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background. Acta Paediatr 94:1608-1614
101. King A, Harris P, Fritzell J, Kurlan R (2006), Syncope in children with Tourette's syndrome treated with guanfacine. Mov Disord 21:419-420
102. King RA, Scahill L, Findley D, Cohen DJ (1999), Psychosocial and behavioral treatments. In: Tourette Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care, Leckman JF, Cohen DJ, eds. New York: Wiley, pp 338-359
103. King RA, Scahill L, Lombroso PJ, Leckman JF (2003), Tourette's syndrome and other tic disorders. In: Pediatric Psychopharmacology, Martin A, Scahill L, Charney DS, Leckman JF, eds. New York: Oxford, pp 526-542
104. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003), Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914-920
105. Kirvan CA, Swedo SE, Snider LA, Cunningham MW (2006), Antibody-mediated neuronal cell signaling in behavior and movement disorders. JNeuroimmunol 179:173-179
106. Kompoliti K, Goetz CG (1998), Hyperkinetic movement disorders misdiagnosed tics in Gilles de la Tourette syndrome. Mov Disord 13:477-480
107. Koos T, Tepper JM (1999), Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 2:467-472
108. Kostanecka-Endress T, Banaschewski T, Kinkelbur J et al. (2003), Disturbed sleep in children with Tourette syndrome: a polysomnographic study. J Psychosom Res 55:23-29
109. Krauss JK, Jankovic J (2002), Head injury and posttraumatic movement disorders. Neurosurgery 50:927-939
110. Kurlan R, Como PG, Miller B et al. (2002), The behavioral spectrum of tic disorders: a community-based study. Neurology 59:414-420
111. Kushner HI (1999), A Cursing Brain? The Histories of Tourette Syndrome. Cambridge, MA: Harvard University Press
112. Kwak C, Vuong KD, Jankovic J (2003a), Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 18:1530-1533
113. Kwak CH, Hanna PA, Jankovic J (2000), Botulinum toxin in the treatment of tics. Arch Neurol 57:1190-1193
114. Kwak C, Vuong KD, Jankovic J (2003b), Migraine headache in patients with Tourette syndrome. Arch Neurol 60:1595-1598
115. Leckman JF (2002), Tourette's syndrome. Lancet 360:1577-1586
116. Leckman JF, Cohen DJ (1999), Evolving models of pathogenesis. In: Tourette's Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care, Leckman JF, Cohen DJ, eds. New York: Wiley, pp 155-176
117. Leckman JF, Katsovich L, Lin H et al. (2005), Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 57:667-673
118. Leckman JF, King RA, Cohen DJ (1999b), Tics and tic disorders. In: Tourette's Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care, Leckman JF, Cohen DJ, eds. New York: Wiley, pp 23-42
119. Leckman JF, Pauls DL, Zhang H et al., and the Tourette Syndrome Association International Consortium for Genetics (2003), Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 116: 60-68
120. Leckman JF, Riddle MA (2000), Tourette's syndrome: when habit forming units form habits of their own? Neuron 28:349-354
121. Leckman JF, Vaccarino FM, Kalanithi PSA, Rothenberger A (2006), Tourette syndrome: a relentless drumbeat. J Child Psychol Psychiatry 47:537-550
122. Leckman JF, Zhang H, Vitale A et al. (1998), Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102:14-19
123. Lee CC, Chou IC, Tsai CH, Wang TR, Li TC, Tsai FJ (2005), Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr Neurol 33:272-276
124. Lin H, Katsovich L, Ghebremichael M et al. (2006), Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 48:157-166
125. Lin HQ, Yeh C-B, Peterson BS et al. (2002), Assessment of symptom exacerbations in a longitudinal study of children with Tourette syndrome or obsessive-compulsive disorder. J Am Acad Child Adolescent Psychiatry 41:1070-1077
126. Lipinski JF, Sallee FR, Jackson C, Sethuraman G (1997), Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord 12:402-407
127. Llinas R, Urbano FJ, Leznik E, Ramirez RR, van Marle HJ (2005), Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect. Trends Neurosci 28:325-333
128. Loiselle J, Wendtlandt JT, Rohde CA, Singer HS (2003), Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatr Neurol 28:119-125
129. Ludolph AG, Juengling FD, Libal G, Ludolph AC, Fegert JM, Kassubek J (2006), Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry 188:484-485
130. Luo F, Leckman JF, Katsovich L et al. (2004), Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 113:e578-e585
131. Maia AS, Barbosa ER, Menezes PR, Miguel EC (1999), Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia. Rev Hosp Clin Fac Med Sao Paulo 54:213-221
132. Mahone EM, Koth CW, Cutting L, Singer HS, Denckla MB (2001), Executive function in fluency and recall measures among children with Tourette syndrome or ADHD. J Int Neuropsychol Soc 7:102-111
133. Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA (2001), Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Acad Child Adolesc Psychiatry 40:887-894
134. Mantel BJ, Meyers A, Tran QY, Rogers S, Jacobson JS (2004), Nutritional supplements and complementary/alternative medicine in Tourette syndrome. J Child Adolesc Psychopharmacol 14:582-589
135. Marras C, Andrews D, Sime E, Lang AE (2001), Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 56:605-610
136. Marsh R, Alexander GM, Packard MG et al. (2004), Habit learning in Tourette syndrome: a translational neuroscience approach to a developmental psychopathology. Arch Gen Psychiatry 61:1259-1268
137. Marsh R, Alexander GM, Packard MG, Zhu H, Peterson BS (2005), Perceptual-motor skill learning in Gilles de la Tourette syndrome. Evidence for multiple procedural learning and memory systems. Neuropsychologia 43:1456-1465
138. Martin A, Scahill L, Charney DS, Leckman JF (2003), Pediatric Psychopharmacology. New York: Oxford
139. Mathews CA, Bimson B, Lowe TL et al. (2006), Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psych 163:1066-1073
140. Mathews CA, Reus VI, Bejarano J et al. (2004), Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet 14:13-23
141. McDougle CJ, Kem DL, Posey DJ (2002), Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry 41:921-927
142. McMahon WM, Carter AS, Fredine N, Pauls DL (2003), Children at familial risk for Tourette's disorder: child and parent diagnoses. Am J Med Genet B Neuropsychiatr Genet 121:105-111
143. Mell LK, Davis RL, Owens D (2005), Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 116:56-60
144. Mercadante MT, Campos MC, Marques-Dias MJ, Miguel EC, Leckman J (1997), Vocal tics in Sydenham's chorea. J Am Acad Child Adolesc Psychiatry 36:305-306
145. Merette C, Brassard A, Potvin A et al. (2000), Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67:1008-1013
146. Middleton FA, Strick PL (2000), Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 31:236-250
147. Miguel EC, Leckman JF, Rauch S et al. (2005), The obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 10:258-275
148. Mink JW (2001), Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatr Neurol 25:190-198
149. Mink JW (2006), Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. Adv Neurol 99:89-98
150. Mink JW, Walkup J, Frey KA et al., Tourette Syndrome Association, Inc. (2006), Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 21:1831-1838
151. Moll GH, Wischer S, Heinrich H, Tergau F, Paulus W, Rothenberger A (1999), Deficient motor control in children with tic disorder: evidence from transcranial magnetic stimulation. Neurosci Lett 272:37-40
152. Morris G, Arkadir D, Nevet A, Vaadia E, Bergman H (2004), Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43:133-143
153. Morshed SA, Parveen S, Leckman JF et al. (2001), Antibodies against striatal, nuclear, cytoskeletal and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 50:566-578
154. Muller N (2004), Anti-inflammatory therapy with a COX-2 inhibitor in Tourette's syndrome. Inflammopharmacology 12:271-275
155. Muller N, Kroll B, Schwarz MJ et al. (2001), Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res 101:187-193
156. Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele-Horn M (2004), Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res 129:119-125
157. Muller N, Riedel M, Forderreuther S, Blendinger C, Abele-Horn M (2000), Tourette's syndrome and Mycoplasma pneumoniae infection. Am J Psychiatry 157:481-482
158. Muller SV, Johannes S, Wieringa B et al. (2003), Disturbed monitoring and response inhibition in patients with Gilles de la Tourette syndrome and co-morbid obsessive compulsive disorder. Behav Neurol 14:29-37
159. Müller-Vahl KR, Berding G, Brucke T et al. (2000), Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol 247:514-520
160. Nicolson R, Craven-Thuss B, Smith J, McKinlay BD, Castellanos FX (2005), A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. J Am Acad Child Adolesc Psychiatry 44:640-646
161. Nestadt G, Samuels JF, Riddle MA et al. (2002), Obsessive-compulsive disorder: defining the phenotype. J Clin Psychiatry 63:5-7
162. Onofrj M, Paci C, D'Andrematteo G, Toma L (2000), Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double blind cross over study vs. low-dose pimozide. J Neurol 247:443-446
163. Ozonoff S, Jensen J (1999), Brief report: specific executive function profiles in three neurodevelopmental disorders. J Autism Dev Disord 29:171-177
164. Padala PR, Qadri SF, Madaan V (2005), Aripiprazole for the treatment of Tourette's disorder. J Clin Psychiatry 7:296-299
165. Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S (2003), Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 61:936-940
166. Pauls DL (2003), An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 55:7-12
167. Pediatric OCD Treatment Study (POTS) Team (2004), Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969-1976
168. Perlmutter SJ, Leitman SF, Garvey MA et al. (1999), Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153-1158
169. Perrin EM, Murphy ML, Casey JR et al. (2004), Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 158:848-856
170. Peterson BS, Leckman JF (1998), The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 44:1337-1348
171. Peterson BS, Pine DS, Cohen P, Cook J (2001a), Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 40:685-695
172. Peterson BS, Skudlarski P, Anderson AW et al. (1998a), A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 55:326-333
173. Peterson BS, Staib L, Scahill L et al. (2001b), Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 58:427-440
174. Peterson BS, Thomas P, Kane MJ et al. (2003), Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 60:415-424
175. Peterson BS, Zhang H, Anderson GM, Leckman JF (1998b), A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. J Clin Psychopharmacol 18:324-331
176. Piacentini J, Chang S (2001), Behavioral treatments for Tourette syndrome in tic disorders: state of the art. Adv Neurol 85:319-331
177. Plessen KJ, Wentzel-Larsen T, Hugdahl K et al. (2004), Altered interhemispheric connectivity in individuals with Tourette syndrome. Am J Psychiatry 161:2028-2037
178. Porta M, Maggioni G, Ottaviani F, Schindler A (2004), Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A. Neurol Sci 24:420-423
179. Riedel M, Straube A, Schwarz MJ, Wilske B, Muller N (1998), Lyme disease presenting as Tourette's syndrome. Lancet 351:418-419
180. Robertson MM (2003), Diagnosing Tourette syndrome. Is it a common disorder? J Psychosom Res 55:3-6
181. Robertson MM, Banerjee S, Kurlan R et al. (1999), The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology 53:2108-2112
182. Sallee FR, Kurlan R, Goetz CG et al. (2000), Ziprasidone treatment of children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 39:292-299
183. Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G (1997), Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 154:1057-1062
184. Sanberg PR, Shytle RD, Silver AA (1998), Treatment of Tourette syndrome with mecamylamine. Lancet 352:705-706
185. Sandor P (2003), Pharmacological management of tics in patients with TS. J Psychosom Res 55:41-48
186. Saunders-Pullman R, Braun I, Bressman S (1999), Pediatric movement disorders. Child Adolesc Psychiatr Clin N Am 8:747-765
187. Scahill L (2005), Adding psychosocial therapy to methylphenidate may not
188. Scahill L, Chappell PB, Kim YS et al. (2001a), A placebo-controlled study of guanficine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067-1074
189. Scahill L, Erenberg G, Berlin CM Jr et al., Tourette Syndrome Association Medical Advisory Board: Practice Committee (2006), Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 3:192-206
190. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS (2003), A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60:1130-1135
191. Scahill L, Lombroso PJ, Mack G et al. (2001b), Thermal sensitivity in Tourette syndrome: preliminary report. Percept Mot Skills 92:419-432
192. Scahill L, Sukhodolsky DG, Williams SK, Leckman JF (2005), Public health significance of tic disorders in children and adolescents. Adv Neurol 96:240-248
193. Schultz RT, Carter AS, Gladstone M et al. (1998), Visual-motor integration functioning in children with Tourette syndrome. Neuropsychology 12:134-145
194. Segawa M (2003), Neurophysiology of Tourette's syndrome: pathophysiological considerations. Brain Dev 25:S62-S69
195. Serra-Mestres J, Ring HA, Costa DC et al. (2004), Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Acta Psychiatr Scand 109:140-146
196. Serrien DJ, Nirkko AC, Loher TJ, Lovblad KO, Burgunder JM, Wiesendanger M (2002), Movement control of manipulative tasks in patients with Gilles de la Tourette syndrome. Brain 125:290-300
197. Serrien DJ, Orth M, Evans AH, Lees AJ, Brown P (2005), Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence. Brain 128:116-125
198. Silver AA, Shytle RD, Philipp MK, Sanberg PR (2001a), Case study: longterm potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 35:1631-1636
199. Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR (2001b), Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo controlled study. J Clin Psychiatry 62:707-714
200. Silver AA, Shytle RD, Sheehan KH, Ramos A, Sanberg PR (2001c), Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Am Acad Child Adolesc Psychiatry 40:1103-1110
201. Simonic I, Gericke GS, Ott J, Weber JL (1998), Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population. Am J Hum Genet 63:839-846
202. Singer HS, Giuliano JD, Hansen BH et al. (1998), Antibodies against human putamen in children with Tourette syndrome. Neurology 50:1618-1624
203. Singer HS, Hong JJ, Yoon DY, Williams PN (2005), Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65:1701-1707
204. Singer HS, Szymanski S, Giuliano J et al. (2002), Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry 159:1329-1336
205. Singer HS, Wendlandt J, Krieger M, Giuliano J (2001), Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 56:599-604
206. Snider LA, Lougee L, Slattery M, Grant P, Swedo SE (2005), Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 57:788-792
207. Snider LA, Seligman LD, Ketchen BR et al. (2002), Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 110:331-336
208. Snider LA, Swedo SE (2004), PANDAS: current status and directions for research. Mol Psychiatry 9:900-907
209. Spencer T, Biederman J, Harding M et al. (1998), Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry 39:1037-1044
210. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T (2001), Tourette disorder and ADHD. Adv Neurol 85:57-87
211. Stamenkovic M, Schindler SD, Aschauer HN et al. (2000), Effective openlabel treatment of Tourette disorder with olanzapine. Int Clin Psychopharmacol 15:23-28
212. State MW, Greally J, Cuker A et al. (2003), Epigenetic abnormalities associated with a chromosome 18q(21-22) and a Gilles de la Tourette syndrome phenotype. Proc Natl Acad Sci U S A 100:4684-4689
213. Stephens RJ, Bassel C, Sandor P (2004), Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome - a pilot study. J Child Adolesc Psychopharmacol 14:255-266
214. Stern E, Silbersweig DA, Chee KY et al. (2000), A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 57:741-748
215. Storch EA, Murphy TK, Geffken GR et al. (2005), Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess 17:486-491
216. Sukhodolsky DG, do Rosario-Campos MC, Scahill L et al. (2005), Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder. Am J Psychiatry 162:1125-1132
217. Sukhodolsky DG, Kassinove H, Gorman BS (2004), Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis. Aggression Violent Behav 9:247-269
218. Sukhodolsky DG, Scahill L, Zhang H et al. (2003), Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry 42:98-105
219. Swain JE, Leckman JF (2003), Tourette's syndrome in children. Curr Treat Options Neurol 5:299-308
220. Swedo SE, Leonard HL, Garvey M et al. (1998), Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155:264-271
221. Swerdlow NR, Braff DL, Geyer MA (2000), Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185-204
222. Swerdlow NR, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A (2001), Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an BfMRI-friendly startle paradigm. Biol Psychiatry 50:578-585
223. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR (2005), Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 62:210-215
224. Taylor JR, Morshed SA, Parveen S et al. (2002), An animal model of Tourette's syndrome. Am J Psychiatry 159:657-660
225. Toren P, Laor N, Cohen DJ, Wolmer L, Weizman A (1999), Odansetron treatment in patients with Tourette's syndrome. Int Clin Psychopharmacol 14:373-376
226. Toren P, Weizman A, Ratner S, Cohen D, Laor N (2005), Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 66:499-503
227. Tourette Syndrome Association International Consortium for Genetics (1999), A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 65:1428-1436
228. Tourette's Syndrome Study Group (2002), Treatment of ADHD in children with tics. A randomized controlled trial. Neurology 58:527-536
229. Tucker DM, Leckman JF, Scahill L et al. (1996), A putative poststreptococcal case of ocd with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry 35:1684-1691
230. van der Linden C, Colle H, Vandewalle V, Alessi G, Rijckaert D, De Waele L (2002), Successful treatment of tics with bilateral internal pallidum (GPi) stimulation in a 27-year-old male patient with Gilles de la Tourette's syndrome. Mov Disord 17:1130
231. Vandewalle V, van der Linden C, Groenewegen HJ, Caemaert J (1999), Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353:724
232. Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA (2004), Exposure with response prevention versus habit reversal in Tourette's syndrome: a controlled study. Behav Res Ther 42:501-511
233. Verkerk AJMH, Mathews CA, Joosse M, Eussen BHJ, Heutink P, Oostra BA, Tourette Syndrome Association International Consortium for Genetics (2003), CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82:1-9
234. Visser-Vandewalle V, Temel Y, Boon P et al. (2003), Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 99:1094-1100
235. Visser-Vandewalle V, Temel Y, van der Linden CH, Ackermans L, Beuls E (2004), Deep brain stimulation in movement disorders. The applications reconsidered. Acta Neurol Belg 104:33-36
236. Wang HS, Kuo MF (2003), Tourette's syndrome in Taiwan: an epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev 25(suppl 1):S29-S31
237. Wendlandt JT, Grus FH, Hansen BH, Singer HS (2001), Striatal antibodies in children with Tourette's syndrome: multivariate discriminant analysis of IgG repertoires. J Neuroimmunol 119:106-113
238. Whitaker AH, Van Rossem R, Feldman JF et al. (1997), Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities. Arch Gen Psychiatry 54:847-856
239. Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L (2003), Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry 160:1175-1177
240. Wolf SS, Jones DW, Knable MB et al. (1996), Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225-1227
241. World Health Organization (1998), Multiaxial Classification of Child and Adolescent Psychiatric Disorders-International Classification of Disease and Related Health Problems, 10th Revision (ICD-10). Cambridge: Cambridge University Press
242. Woods DW, Piacentini J, Himle MB, Chang S (2005), Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with tic disorders. J Dev Behav Pediatr 26:397-403
243. Xu Q, de la Cruz E, Anderson SA (2003), Cortical interneuron fate determination: diverse sources for distinct subtypes? Cereb Cortex 13:670-676
244. Yuen T, Bradshaw JL, Sheppard D, Lee P, Georgiou-Karistianis N (2005), Inhibition of return in children with Tourette's syndrome and comorbid forms: a preliminary study. Child Neuropsychol 11:393-411
245. Zhang H, Leckman JF, Tsai C-P, Kidd KK, Rosario Campos MC (2002), The Tourette Syndrome Association International Consortium for Genetics. Genome wide scan of hoarding in sibling pairs both diagnosed with Gilles de la Tourette syndrome. Am J Hum Genet 70:896-904
246. Zheng T, Wilson CJ (2002), Corticostriatal combinatorics: the implications of corticostriatal axonal arborizations. J Neurophysiol 87:1007-1017
247. Ziemann U, Paulus W, Rothenberger A (1997), Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 154:1277-1284